Shares in Crucell NV surged more than 55 percent Friday on news that Johnson & Johnson, which already holds a 17.9 percent stake in the company, was lining up a €1.75 billion (US$2.3 billion) bid, valued at €24.75 per share, to acquire the Dutch vaccine maker outright. (BioWorld International)
Shares in Crucell NV surged more than 55 percent Friday on news that Johnson & Johnson, which already holds a 17.9 percent stake in the company, was lining up a €1.75 billion (US$2.3 billion) bid, valued at €24.75 per share, to acquire the Dutch vaccine maker outright. (BioWorld Today)
Shares in Santhera Pharmaceuticals AG rose more than 8 percent Friday on news of a European partnering deal with Ipsen Group SA, worth up to €141 million (US$181 million), for its Parkinson's drug Fipamezole. (BioWorld International)
